Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Total 13F shares
-
1,954,510
-
Share change
-
-134,646
-
Total reported value
-
$149,403
-
Price per share
-
$0.00
-
Number of holders
-
15
-
Value change
-
-$10,107
-
Number of buys
-
1
-
Number of sells
-
5
Institutional Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q1 2022
As of 31 Mar 2022,
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,954,510 shares.
The largest 10 holders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, Owl Creek Asset Management, L.P., Ionic Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Shaolin Capital Management LLC, Privium Fund Management B.V., ZAZOVE ASSOCIATES LLC, EQUITEC PROPRIETARY MARKETS, LLC, HRT FINANCIAL LP, and Walleye Capital LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.